Results

Total Results: 1,112 records

Showing results for "phase".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-2-nonopioid-pharm-chronic-pain.pdf
    April 01, 2022 - Efficacy and safety of fasinumab in patients with chronic low back pain: a phase II/III randomised … in patients with knee pain due to osteoarthritis: an exploratory post hoc analysis of a Japanese phase … or chronic low back pain with early pain reduction: an exploratory post- hoc analysis of Japanese phase … Open- label phase 3 study of diclofenac conjugated to hyaluronate (diclofenac etalhyaluronate: ONO- … ][TM]s effect in Chinese patients with chronic pain due to osteoarthritis: post hoc analyses of a phase
  2. effectivehealthcare.ahrq.gov/products/safety-vaccines/protocol
    April 06, 2020 - 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 (152174) ("clinical trial" or "clinical trial, phase … i" or "clinical trial, phase ii" or clinical trial, phase iii or clinical trial, phase iv or controlled … randomized controlled trial").pt. or double-blind method/ or clinical trials as topic/ or clinical trials, phase … i as topic/ or clinical trials, phase ii as topic/ or clinical trials, phase iii as topic/ or clinical … trials, phase iv as topic/ or controlled clinical trials as topic/ or randomized controlled trials as
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cultural-competence_research-protocol.pdf
    July 09, 2014 - The literature set identified at this phase will be examined from a content analysis perspective for …  ii.pt.   41   clinical  trial,  phase  iii.pt.   42   clinical  trial,  phase …  i.pt.   40   clinical  trial,  phase  ii.pt.   41   clinical  trial,  phase   … iii.pt.   42   clinical  trial,  phase  iv.pt.   43   controlled  clinical  trial.pt …  i.pt.   40   clinical  trial,  phase  ii.pt.   41   clinical  trial,  phase  
  4. #05 DEPRESSION (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/05_depression_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - inclusion are those interventions expected to be within 0–4 years of potential diffusion (e.g., in phase … Results The table below lists the seven topics for which (1) preliminary phase III data on drugs or … Mifepristone for treating PMD is being investigated in one phase III clinical trial. … Three phase III trials did not individually demonstrate statistical superiority of mifepristone over … Paul, MN) are both in phase III development for DBS for MDD.
  5. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/surveillance-report-3-nonopioid-pharm-chronic-pain.pdf
    July 01, 2022 - A randomized, double-blind, placebo- controlled phase III trial of duloxetine in Japanese patients … Randomized, double-blind, placebo- controlled phase III trial of duloxetine monotherapy in Japanese … A randomized, double-blind, placebo- controlled phase III trial of duloxetine in Japanese fibromyalgia … Efficacy and safety of fasinumab in patients with chronic low back pain: a phase II/III randomised … Open- label phase 3 study of diclofenac conjugated to hyaluronate (diclofenac etalhyaluronate: ONO-
  6. effectivehealthcare.ahrq.gov/sites/default/files/functional-limitations-horizon-scan-high-impact-1306.pdf
    June 01, 2013 - Results The table below lists the 17 topics for which (1) preliminary phase III data were available … In phase III trials, icatibant provided significant symptom relief within about 2 hours and initial … Placebo- controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. … Placebo- controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis. … ThromboGenics' microplasmin phase III program progressing according to schedule. [internet].
  7. #05 DEPRESSION (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1312.pdf
    October 01, 2014 - Results The table below lists the five topics for which (1) preliminary phase III data for drugs were … Completed phase III trials did not demonstrate statistical superiority of mifepristone over placebo … Paul, MN) are in phase III development for DBS for treating BPD and MDD. … Reclaim/Activa trials for MDD have an anticipated completion date of October 2014; phase III trials … III clinical trial.9 Three completed phase III trials did not demonstrate superiority of mifepristone
  8. effectivehealthcare.ahrq.gov/sites/default/files/ptsd-comments.pdf
    November 04, 2020 - Since the Phase 1 work and report, we have worked closely with the National Center for PTSD to obtain … Since the Phase 1 work and report, we have worked closely with the National Center for PTSD to obtain … For this phase of development, as recommended by the TEP and NCPTSD, treatments were categorized according … of the PTSD-Repository and updated in this next phase of work. … in a subsequent article highlighting the updates to the PTSD- Repository completed in this second phase
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-comments.pdf
    November 04, 2020 - Since the Phase 1 work and report, we have worked closely with the National Center for PTSD to obtain … Since the Phase 1 work and report, we have worked closely with the National Center for PTSD to obtain … For this phase of development, as recommended by the TEP and NCPTSD, treatments were categorized according … of the PTSD-Repository and updated in this next phase of work. … in a subsequent article highlighting the updates to the PTSD- Repository completed in this second phase
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0086_04-01-2009.pdf
    January 01, 2009 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND__0355_09-22-2010.pdf
    January 01, 2010 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0030_06-19-2008.pdf
    January 01, 2008 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0215_01-06-2010.pdf
    January 01, 2010 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0074_03-10-2009.pdf
    January 01, 2009 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0278_03-10-2008.pdf
    January 01, 2008 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0283_03-10-2008.pdf
    January 01, 2008 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase
  17. #05 DEPRESSION (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/05_depression_potential_high_impact_june_2012.pdf
    January 01, 2012 - Results The table below lists the 12 topics for which (1) preliminary phase III data on drugs or phase … Mifepristone for treating PMD is being investigated in one phase III clinical trial. … Reclaim is in phase III trials for MDD with an anticipated completion date of October 2014; Libra is … also in phase III trials. … Jude Medical is evaluating its Libra ® DBS system for treatment-resistant depression in the phase
  18. effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in phase … None of these topics emerged as eligible for inclusion in this report because preliminary phase III … These topics were ineligible for consideration in this report because no phase III data were available
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-protocol_amended110619.pdf
    November 02, 2019 - versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase … Patients With Low- Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy: A Phase … 26 (763246) 29 27 and 28 (43063) 30 limit 29 to (clinical trial, all or clinical trial, phase … i or clinical trial, phase ii or clinical trial, phase iii or clinical trial, phase iv or clinical
  20. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/surveillance-report-3-noninvasive-nonpharma.pdf
    August 01, 2022 - Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine … Lasmiditan is an effective acute treatment for migraine: a phase 3 randomized study. … Rimegepant for the acute treatment of migraine: subgroup analyses from 3 phase 3 clinical trials by … STOP 301: A Phase 3, open-label study of safety, tolerability, and exploratory efficacy of INP104, … Evaluation of injection-site-related adverse events with galcanezumab: a post hoc analysis of phase

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: